NCT04659616 2025-12-19Pemigatinib After Chemotherapy for the Treatment of Newly Diagnosed Acute Myeloid LeukemiaOHSU Knight Cancer InstitutePhase 1 Recruiting32 enrolled
NCT00667485 2014-01-17Rapamycin Plus Bevacizumab in Advanced CancersUniversity of ChicagoPhase 1 Completed28 enrolled